XML 53 R39.htm IDEA: XBRL DOCUMENT
v3.25.2

SEGMENT REPORTING (Tables) | 6 Months Ended
--- | ---
Jun. 30, 2025
Segment Reporting [Abstract] |
SCHEDULE OF REVENUES, OPERATING EXPENSES AND OPERATING INCOME (LOSS) BY REPORTABLE SEGMENT | SCHEDULE OF REVENUES, OPERATING EXPENSES AND OPERATING INCOME (LOSS) BY REPORTABLE SEGMENT
|  | Healthcare IT |  |  | Medical Practice Management |  |  | Total |
|  | Six Months Ended June 30, 2025 |
|  | ($ in thousands) |
|  | Healthcare IT |  |  | Medical Practice Management |  |  | Total |
Net revenue |  | $ | 48,719 |  |  | $ | 6,290 | (a) |  | $ | 55,009 |
Operating expenses: |  |  |  |  |  |  |  |  |  |  |  |
Direct operating costs |  |  | 24,666 |  |  |  | 5,278 |  |  |  | 29,944 |
Selling and marketing |  |  | 2,234 |  |  |  | 15 |  |  |  | 2,249 |
General and administrative |  |  | 4,455 |  |  |  | 1,211 |  |  |  | 5,666 |
Research and development |  |  | 2,255 |  |  |  | - |  |  |  | 2,255 |
Depreciation and amortization |  |  | 6,555 |  |  |  | 164 |  |  |  | 6,719 |
Restructuring costs |  |  | 137 |  |  |  | - |  |  |  | 137 |
Total operating expenses |  |  | 40,302 |  |  |  | 6,668 |  |  |  | 46,970 |
Segment operating income (loss) |  | $ | 8,417 |  |  | $ | (378 | ) |  | $ | 8,039 |
Reconciliation of profit or loss (segment profit/loss): |  |  |  |  |  |  |  |  |  |  |  |
Unallocated corporate expenses |  |  |  |  |  |  |  |  |  | $ | (3,024 | )
Net interest expense |  |  |  |  |  |  |  |  |  |  | (33 | )
Other expenses |  |  |  |  |  |  |  |  |  |  | (49 | )
Income before income taxes |  |  |  |  |  |  |  |  |  | $ | 4,933 |
(a) This revenue represents fees based on our actual costs plus a percentage of the operating profit.
|  | Healthcare IT |  |  | Medical Practice Management |  |  | Total |
|  | Three Months Ended June 30, 2025 |
|  | ($ in thousands) |
|  | Healthcare IT |  |  | Medical Practice Management |  |  | Total |
Net revenue |  | $ | 24,077 |  |  | $ | 3,300 | (a) |  | $ | 27,377 |
Operating expenses: |  |  |  |  |  |  |  |  |  |  |  |
Direct operating costs |  |  | 11,763 |  |  |  | 2,717 |  |  |  | 14,480 |
Selling and marketing |  |  | 1,110 |  |  |  | 8 |  |  |  | 1,118 |
General and administrative |  |  | 2,343 |  |  |  | 569 |  |  |  | 2,912 |
Research and development |  |  | 1,020 |  |  |  | - |  |  |  | 1,020 |
Depreciation and amortization |  |  | 3,300 |  |  |  | 82 |  |  |  | 3,382 |
Restructuring costs |  |  | 23 |  |  |  | - |  |  |  | 23 |
Total operating expenses |  |  | 19,559 |  |  |  | 3,376 |  |  |  | 22,935 |
Segment operating income (loss) |  | $ | 4,518 |  |  | $ | (76 | ) |  | $ | 4,442 |
Reconciliation of profit or loss (segment profit/loss) |  |  |  |  |  |  |  |  |  |  |  |
Unallocated corporate expenses |  |  |  |  |  |  |  |  |  |  | (1,446 | )
Interest expense |  |  |  |  |  |  |  |  |  |  | (17 | )
Other expenses |  |  |  |  |  |  |  |  |  |  | (35 | )
Income before income taxes |  |  |  |  |  |  |  |  |  | $ | 2,944 |
(a) This revenue represents fees based on our actual costs plus a percentage of the operating profit.
|  | Healthcare IT |  |  | Medical Practice Management |  |  | Total |
|  | Six Months Ended June 30, 2024 |
|  | ($ in thousands) |
|  | Healthcare IT |  |  | Medical Practice Management |  |  | Total |
Net revenue |  | $ | 47,301 |  |  | $ | 6,751 | (a) |  | $ | 54,052 |
Operating expenses: |  |  |  |  |  |  |  |  |  |  |  |
Direct operating costs |  |  | 25,254 |  |  |  | 5,165 |  |  |  | 30,419 |
Selling and marketing |  |  | 3,417 |  |  |  | 17 |  |  |  | 3,434 |
General and administrative |  |  | 4,602 |  |  |  | 911 |  |  |  | 5,513 |
Research and development |  |  | 1,968 |  |  |  | - |  |  |  | 1,968 |
Depreciation and amortization |  |  | 7,478 |  |  |  | 166 |  |  |  | 7,644 |
Restructuring costs |  |  | 438 |  |  |  | - |  |  |  | 438 |
Total operating expenses |  |  | 43,157 |  |  |  | 6,259 |  |  |  | 49,416 |
Segment operating income |  | $ | 4,144 |  |  | $ | 492 |  |  | $ | 4,636 |
Reconciliation of profit or loss (segment profit/loss): |  |  |  |  |  |  |  |  |  |  |  |
Unallocated corporate expenses |  |  |  |  |  |  |  |  |  | $ | (2,236 | )
Net interest expense |  |  |  |  |  |  |  |  |  |  | (602 | )
Other income |  |  |  |  |  |  |  |  |  |  | (287 | )
Income before income taxes |  |  |  |  |  |  |  |  |  | $ | 1,511 |
(a) This revenue represents fees based on our actual costs plus a percentage of the operating profit.
|  | Healthcare IT |  |  | Medical Practice Management |  |  | Total |
|  | Three Months Ended June 30, 2024 |
|  | ($ in thousands) |
|  | Healthcare IT |  |  | Medical Practice Management |  |  | Total |
Net revenue |  | $ | 24,580 |  |  | $ | 3,510 | (a) |  | $ | 28,090 |
Operating expenses: |  |  |  |  |  |  |  |  |  |  |  |
Direct operating costs |  |  | 12,710 |  |  |  | 2,532 |  |  |  | 15,242 |
Selling and marketing |  |  | 1,657 |  |  |  | 7 |  |  |  | 1,664 |
General and administrative |  |  | 2,021 |  |  |  | 477 |  |  |  | 2,498 |
Research and development |  |  | 1,055 |  |  |  | - |  |  |  | 1,055 |
Depreciation and amortization |  |  | 3,633 |  |  |  | 81 |  |  |  | 3,714 |
Restructuring costs |  |  | 116 |  |  |  | - |  |  |  | 116 |
Restructuring costs |  |  | 116 |  |  |  | - |  |  |  | 116 |
Total operating expenses |  |  | 21,192 |  |  |  | 3,097 |  |  |  | 24,289 |
Segment operating income |  | $ | 3,388 |  |  | $ | 413 |  |  | $ | 3,801 |
Reconciliation of profit or loss (segment profit/loss) |  |  |  |  |  |  |  |  |  |  |  |
Unallocated corporate expenses |  |  |  |  |  |  |  |  |  |  | (1,530 | )
Interest expense |  |  |  |  |  |  |  |  |  |  | (264 | )
Other expenses |  |  |  |  |  |  |  |  |  |  | (294 | )
Income before income taxes |  |  |  |  |  |  |  |  |  | $ | 1,713 |
(a) | This revenue represents fees based on our actual costs plus a percentage of the operating profit.

X
- Definition Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 25 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-25 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30 + Details
Name: | us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration